So I wrote a little thing for @MolMetab sciencedirect.com/science/articl As we now appreciate, GLP-1 can target multiple brain regions and neuronal populations to reduce food intake, and the clinical results are increasingly impressive #obesity The ongoing SELECT trial will be pivotal for the field sciencedirect.com/science/articl From very modest weight loss with exenatide twice daily, the GLP-1 field has learned, by titration, dose escalation, higher Cmax, and better molecules, to achieve clinically meaningful #weightloss #T2D #obesity More progress to come #obesity described here sciencedirect.com/science/articl Beyond semaglutide and tirzepatide, where might we find the next GLP-1-based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and make projections out to 52 weeks thelancet.com/journals/lance Join the conversation
Rajan, R., Hayashi, F., Nagashima, T
The GMP line is unusual in the research peptide market and positions PekCura Labs differently from vendors offering research-grade-only product
Lifestyle Integration Peptides offer a biochemical advantage, not a complete answer
It's a recognition that the research community is actively exploring these synergistic pathways, and we aim to provide the highest-purity components for that advanced research
The copper-mediated inhibition remains localized, potentially reducing follicle sensitivity to DHT without affecting hormones elsewhere in the body
